CATHERINE MCGAFFEY: Open Payments
NPI 1942890801 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$276 in 12 payments from 9 companies in 2025. Trend: 2023 $260 · 2024 $390 · 2025 $276
Food & beverage: $276
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $110 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| Genentech USA, Inc. | 1 | $26 |
| Cycle Pharmaceuticals Inc | 1 | $23 |
| Celgene Corporation | 1 | $21 |
| EMD Serono, Inc. | 1 | $21 |
| UCB, Inc. | 1 | $19 |
| KYOWA KIRIN, INC. | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: QULIPTA, VYALEV, PONVORY, Ocrevus Zunovo, Tascenso ODT, ZEPOSIA, BOTOX, Rystiggo.
Industry payments across MO — which companies pay providers there.
